应用低温等离子髓核消融术治疗颈椎病

Application of Nucleoplasty of Percutaneous Hypothermic Isoionic Radio Frequency Ablation Treatment in Cervical Syndrome

目的用低温等离子髓核消融术治疗颈椎病,探讨低温等离子的临床应用价值。方法对86例年龄在16～82岁经MRI检查和临床表现确诊的颈椎病患者采用经皮等离子髓核消融术治疗,并且运用视觉模拟评分法(VAS)和Macnab评分法对其疗效进行观察分析。结果本组全部患者经3～18个月的随访,平均10个月。86例患者症状有不同程度改善,总有效率为86.7%。术前VAS评分平均为6.11±0.32分,术后随访3～18个月的VAS评分平均为1.71±0.52分。据改良Macnab疗效评定标准,治疗效果优55例,良9例,可10例,差12例,有效率86.7%。无一例出现严重并发症。结论在严格掌握其适应证的情况下,等离子髓核消融术具有操作简单、安全、创伤小、近期疗效优的特点,是一种有效的治疗颈椎病的微创介入手术。

Objective To introduce the application of nucleoplasty of percutaneous hypothermic isoionic radio requency ablation ter- atment with cervical syndrome and evaluate the clinical value of nucleoplasty of percutaneous hypothermic isoionic radio frequency ablation treatment. Methods A total of 86 cases at the age of 16 to 82 years old with cervical syndrome confirmed by MRI and received pereuta- neous nucleoplasty were analyzed retrospectively by visual analogue score（ VAS） and postoperative Macnab score. Results All cases were followed- up from 3 to 18 months （average 10 months） after operation. The symtoms of 86 cases had improvement in different degrees. The total effective rate was 86.7% . The preoperative and post - operative from 3 to 18 months average VAS scores were 6.11 ± 0.32 and 1.71±0.52 respectively. According to the modified Macnab therapeutic evaluation criteria,excellent result was seen in 55,good result in 9, fair result in 10 and poor result in 12 cases,with a total effective rate of 86.7%. No serious complications occurred in all patients. Conclu- sion Under mastering indications strictly,the pereutaneous nucleoplasty possesses many advantages,including simple manipulation, safe, minimally invasive and curative effect well in the near future. It is an effective,and safe interventional method of cervical syndrome.